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Abstract
Background: Opioid use on a stable methadone dose is a health concern in Iran, the most populous Persian Gulf country. However,
the underlying reasons associated with opioid use have not been studied.
Objectives: The study aimed to explore the reasons associated with opioid use among a group of Persian methadone-maintained
women. The other aim was to explore effective interventions to stop this problem.
Methods: The current qualitative study was conducted between June 2008 and December 2009. The study sites included ten large
methadone treatment clinics in Tehran. The study employed semi-structured interviews with 50 women. Six roundtable meetings
were conducted with nine key informants. NVivo 10 was used to thematically analyze the data.
Results: Women were on a stable methadone dose of 45 - 115 mg for at least six months. Opioid availability, an opioid-dependent
lifestyle, peer pressure and self-treatment were the reasons of opioid use. The provision of cognitive-behavioral therapy, life skills,
observational learning, and mental health services were the suggested interventions to stop opioid use.
Conclusions: Opioid use on a stable methadone dose had been facilitated by some factors which should be considered in
methadone treatment. The suggested interventions should be considered in increasing methadone treatment outcomes.
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1. Background
Opioid use is a health problem in Iran, a vast Per-
sian country in Western Asia (1, 2). This is because of
Afghanistan which smuggles opioids to Iran. It is esti-
mated that two million people are dependent on illicit
drugs. Women are almost ten percent of illicit drug users.
The mental health survey of Iran (Iran MHS) is a large
household study. Overall, 3,366 men and 4,475 women
in the general population were interviewed in 2011. The
prevalence of 12-month substance use disorders was 2.09%
and 2.44% among women and men respectively. Opioids
were the main illicit drugs (3).
Illicit drug use especially opioid use demands an effec-
tive treatment. Drug treatment centers were established
between 1974 and 1977. Over the same time, 30,000 pa-
tients were in treatment (4). Illicit drug use was considered
as a criminal activity between 1979 and 2000. Therefore,
drug treatment was not provided. Since 2000, methadone
clinics have been opened (5). The number of these clinics
has increased from 4,275 in 2014 to 5,983 in 2016. The cen-
ters provide treatment to more than 750,000 clients (6).
Female drug services have been also established. Five
women-only methadone treatment centers were estab-
lished in five provinces between 2007 and 2008. A survey
indicated that 442 women were admitted at the centers by
the end of March 2008. Methadone treatment and harm re-
duction services were the most provided programs. More
than 6,000 women were admitted between 2007 and 2014.
A survey indicated that 2,100 women were admitted at least
once to receive treatment by the end of April 2014 (7). Re-
cently, the number of such centers is 29 (7).
Despite providing methadone treatment, opioid use is
a problem among women. This is related to drug-using
families and friends who facilitate opioid use among Per-
sian women (8-10). This is a health concern because opioid
use reduces methadone treatment outcomes (11-13). There
is no study to show the reasons associated with this prob-
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lem. Furthermore, it is not clear how this problem can be
ceased.
2. Objectives
The study aimed to explore the reasons associated with
opioid use among methadone-maintained women. A sec-
ondary aim was to explore effective interventions to stop
this problem.
3. Materials andMethods
3.1. Design and Settings
The study design was qualitative. The study was con-
ducted between June 2008 and December 2009. Ten
methadone clinics in Tehran were the study sites. The cen-
ters were selected for the study because they reported high
rates of opioid use in the year before conducting the study.
3.2. Participants
All women were eligible to enter the study if they
1) were at least 18 years and 2) reported being on a sta-
ble methadone dose for at least six months. This was in
compliance with other studies (14, 15). Opioid use was
defined as self-reported use for at least once a week in
methadone treatment over the last six months. Exclusion
criteria included reporting severe drug-related symptoms
and/or severe psychiatric problems. Convenience sam-
pling was the method of participant recruitment. Twenty
eight women were approached by two research members.
Eleven women were recruited through the research adver-
tisements pinned to the notice boards of the clinics. Eleven
women were approached by the manager of each clinic.
Overall, 50 women were screened and recruited by a reg-
istered clinical psychologist who had a long professional
experience in working with drug-dependent women.
3.3. Measure
A guide was developed to facilitate the interview proce-
dure. The guide included information on demographics,
illicit drug use and treatment history. Part of the guide in-
cluded open questions about reasons of opioid use in treat-
ment and effective interventions.
3.4. Data Analysis
Interviews were transcribed verbatim. Data analyses
were thematic. All data were reviewed for accuracy. Data
were imported into NVivo 10 for management and coding.
Data were coded by two research team members (O.M and
S.S), who met regularly with the interview team (Z. AM and
A.M) to discuss emerging themes and revise the coding.
3.5. Quality Control
Data triangulation is part of validating qualitative re-
search (16). Triangulation refers to the use of more than
one method in conducting a qualitative study (17). More
than one researcher was recruited to collect and interpret
data. Different methods of sample taking were used for
data triangulation. The research team used prolonged ex-
posure in the sites, and member checks for methodologi-
cal triangulation.
3.6. Ethical Issues
The study was approved by Tehran University of Medi-
cal Sciences. Participation was confidential and voluntary.
Consent form was obtained.
4. Study Procedure
After the purpose of the study was explained, semi-
structured and face-to-face interviews were individually
conducted in private rooms at the sites. Interviews were
conducted by the fist and fifth authors (Z. AM and A. M).
Each interview took 65 - 90 minutes and was audio-taped.
Women received small gifts for study participation.
Six roundtable meetings were conducted with nine
professional key informants (KIs). KIs included two fe-
male clinical psychologists, two female managers from
two methadone clinics, two male doctors, one female so-
cial worker, and two female nurses. Each meeting was
facilitated by two researchers (A.F and S.S) and took 50 -
60 minutes and was audio-taped. Individual interviews
and roundtable meetings continued until no new theme
emerged in four consecutive interviews. This was done to
assure data saturation (16, 17).
5. Results
5.1. Baseline Characteristics
The mean age of the women was 36 (SD = 11) years. More
than half of the women were currently unmarried. Most of
them reported less than eight years of schooling and were
jobless (n = 21) (see Table 1).
All of the women were users of opioids. Almost half of
the women (n = 26) reported at least eight days of opioid
use in treatment. The remaining women (n = 24) reported
opioid use in a range of 9 - 20 days (medium number = 13
days). The length of the treatment ranged between 9 and
42 months. Women were on a stable methadone dose of 45
- 115 mg for at least six months. The medium methadone
dose was 76 mg.
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Table 1. Women’ Baseline Demographics (n = 50)
Characteristics Number
Age range, year 18 - 60









< 8 years 40






5.2. Reasons and Interventions
The reasons associated with opioid use on a stable
methadone dose and effective interventions to cease this
problem have been reported below.
5.2.1. Opioid Availability
A theme that repeatedly emerged from the narratives
was the availability of inexpensive and impure opioids es-
pecially among women’s families, relatives, neighbors or
drug dealers. More than two thirds of the women did not
enjoy opioid use because they took methadone. However,
opioid availability was the problem.
A 30-year old woman reported:
‘… I can’t stop smoking heroin because I see it in neigh-
borhood. When I take methadone, I experience no heroin
craving. I don’t enjoy but heroin users don’t leave me
alone…’
5.2.2. Cognitive-Behavioral Therapy
A theme that repeatedly emerged from the narratives
confirmed that women had no adequate cognitive and
behavioral skills to cope with opioid availability. Most
women and KIs demonstrated how cognitive-behavioral
therapy (CBT) was needed to reduce the impacts of opioid
availability.
A doctor reported:
‘Methadone is stronger than heroin and opium…We
should hold weekly sessions of CBT to teach relapse preven-
tion techniques…’
5.2.3. An Opioid-Dependent Lifestyle
A theme that gradually emerged from the narratives
was an opioid-dependent lifestyle. Interviewees explained
how long years of opioid use encouraged the women to ig-
nore the side effects of opioid use. This issue was mislead-
ing because women thought that they were capable of opi-
oid use in methadone treatment.
A 39 year-old woman reported:
‘… I’ve smoked opium and impure heroin for more
than 15 years…Methadone stops my craving but what
should I do with my addicted lifestyle?... I need training to
stop it’
5.2.4. Life Skills
Although, an adequate methadone dose was pre-
scribed, an opioid-dependent life style was the main prob-
lem. However, teaching life skills was frequently suggested
by women and KIs to reduce the impact of an opioid-
dependent lifestyle.
A psychologist reported:
‘Methadone treatment stops craving for opioid use but
women cannot easily forget their former lifestyles. Teach-
ing life skills in small groups is needed to change their
lifestyles….’
5.2.5. Peer Pressure
Half of the interviewees described how women’
friends facilitated opioid use in methadone treatment.
Women frequently experienced that they were not able to
refuse opioid use on a stable methadone dose. Women and
KIs explained that opioid-using friends offered opioids to
show intimacy and friendship.
A 42-year old woman reported:
‘… My boy friends buy heroin for me to show friend-
ship and love. Heroin smoking isn’t enjoyable but I don’t
like to lose my friends. I should learn how to stop…’
5.2.6. Observational Learning
KIs frequently demonstrated how simple observa-
tional learning was needed to remind women about the
consequences of accepting peer pressure. Showing docu-
mentary movies about the side effects of opioid use and
setting up colorful photos of women with lost beauty were
suggested to stop the impact of peer pressure.
A social worker reported:
‘… We should show documentary movies about the
side effects of opioid use especially on physical beauty,
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bones, teeth and skin…Methadone clinics should set up
photos of opioid-using women with lost beauty…’
5.2.7. Self-Treatment
A theme that repeatedly emerged from the narratives
indicated that women had poor mental health. Almost
half of the women reported lifetime inpatient psychiatric
hospitalizations, surgical operations and car accidents.
Such physical problems exacerbated psychiatric problems.
Women and KIs demonstrated that how psychiatric comor-
bidities encouraged self-treatment with opioid use.
A 41-year woman reported:
‘… I feel depressed. I had several surgical operations so
my feet are painful. I smoke opium to forget these prob-
lems…’
5.2.8. Mental Health Services
The provision of mental health services was suggested
by women and KIs to cease self-treatment with opioid use
in methadone treatment. Interviewees demonstrated that
mental health services could provide an opportunity to re-
duce mental health problems.
A clinic manager reported:
‘…Some women have no any definite plan for future.
They use heroin or opium to cope with mental health
problems… Professional mental health services are neces-
sary…’
6. Discussion
Methadone treatment can be impacted by opioid use
(18). The study results indicated that opioid availability fa-
cilitated its use in methadone treatment. Drug availabil-
ity in social settings is a main reason for illicit drug use
(19). However, providing CBT was suggested to empower
women against opioid availability. While opioid availabil-
ity is not necessarily associated with opioid use, women
who experience opioid availability may express distress
in craving management. Therefore, learning CBT skills to
manage craving can be effective to cope with opioid avail-
ability (20, 21).
An opioid-dependent life style facilitated opioid use in
treatment. This was likely to prevent women from con-
sidering opioid use as a health problem. A study indi-
cated that a drug-dependent lifestyle was a motivation for
women to continue drug use (8, 9). This problem is un-
likely to be fully ceased with methadone. Teaching life
skills was a suggested intervention to cease opioid use.
Such trainings may assist women in developing skills as-
sociated with behavioral changes.
Peer pressure was another factor associated with opi-
oid use. This problem was likely to be related to the lack
of learning assertive skills to reject opioid users. A study
indicated that male peers offered and provided heroin to
their female counterparts to show friendship and intimacy
(22). Simple observational learning was a suggested strat-
egy to reduce peer pressure. Most of the women were not
educated. They were likely to experience poor learning be-
cause of opioid dependence. Therefore, simple observa-
tional learning might be an intervention to cease opioid
use.
Self-treatment was a reason for opioid use. Women
were likely to ignore the side effects of co-current use of
opioids and methadone. Studies indicate that opioids are
used to self-treat mental health problems by women (23,
24). However, providing mental health services can be
helpful (21). Methadone treatment services should con-
sider the simultaneous provision of mental health ser-
vices.
The current study has several limitations. The
study was limited to a group of opioid-using women
in methadone treatment. Therefore, the study findings
may not be generalizable to opioid-using men and women
in the community. The study had a focus on opioid use
among methadone-maintained women. This may be
different from opioid use among male methadone clients
who are not on a stable methadone dose. Further studies
are suggested.
7. Conclusion
Methadone treatment should be monitored by identi-
fying and managing those factors which can have negative
impacts on women. This should be accompanied with re-
inforcing those factors which can increase positive treat-
ment outcomes. External and internal factors facilitated
opioid use on a stable methadone dose. However, some
interventions were suggested to cease this problem. Such
interventions were self-perceived. Further studies are sug-
gested.
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